Company News

Company News
January 12, 2021
Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method
Vancouver, British Columbia, Canada – January 12, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
January 07, 2021
Leading Microbiologist, Dr. Robert E.W. Hancock Appointed As Executive Chairman of Core One Labs Inc.
Vancouver, British Columbia, Canada – January 7, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
December 31, 2020
Core One Labs Completes Acquisition of Vocan Biotechnologies Inc.
Vancouver, British Columbia, Canada – December 31, 2020 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
December 24, 2020
Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc.
Vancouver, British Columbia, Canada – December 24, 2020 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A14XHT) (the “Company”) is pleased to announce...
Read more
Company News
December 03, 2020
Core One Labs Announces Resumption of Trading
Vancouver, British Columbia, Canada – December 2, 2020 – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) (the “Company”)...
Read more
Company News
November 01, 2020
Core One Labs Provides Update on Financial Statements and Management Cease Trade Order
Vancouver, British Columbia, Canada – July 15, 2020 – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABD), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”). The Company wishes...
Read more